374 related articles for article (PubMed ID: 7936841)
1. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of high-risk pregnancies: a biochemical approach to the dynamic assessment of deviant fetal growth.
Vanhaesebrouck P; Kint J; Van Kets H; Govaert P; Smets K; Defoort P; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):71-6. PubMed ID: 7936841
[TBL] [Abstract][Full Text] [Related]
2. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
[TBL] [Abstract][Full Text] [Related]
3. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
4. Perinatal collagen turnover markers in intrauterine growth restriction.
Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
[TBL] [Abstract][Full Text] [Related]
5. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors.
Reece EA; Wiznitzer A; Le E; Homko CJ; Behrman H; Spencer EM
Obstet Gynecol; 1994 Jul; 84(1):88-95. PubMed ID: 7516515
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
Spong CY; Sherer DM; Ghidini A; Jenkins CB; Seydel FD; Eglinton GS
Obstet Gynecol; 1996 Jul; 88(1):24-8. PubMed ID: 8684756
[TBL] [Abstract][Full Text] [Related]
7. N-terminal propeptide of type III collagen in tracheal fluid and serum in preterm infants at risk for bronchopulmonary dysplasia.
Heikinheimo M; Halila R; Marttinen E; Raivio K
Pediatr Res; 1992 Apr; 31(4 Pt 1):340-3. PubMed ID: 1570200
[TBL] [Abstract][Full Text] [Related]
8. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.
Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K
Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905
[TBL] [Abstract][Full Text] [Related]
9. Concentration of malondialdehyde (MDA) in amniotic fluid and maternal and cord serum in cases of intrauterine growth retardation.
Bazowska G; Jendryczko A
Zentralbl Gynakol; 1994; 116(6):329-30. PubMed ID: 8048286
[TBL] [Abstract][Full Text] [Related]
10. Diabetic pregnancy associated with increased epidermal growth factor in cord serum at term.
Loukovaara M; Leinonen P; Teramo K; Andersson S; Alfthan H; Stenman UH
Obstet Gynecol; 2004 Feb; 103(2):240-4. PubMed ID: 14754690
[TBL] [Abstract][Full Text] [Related]
11. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
[TBL] [Abstract][Full Text] [Related]
12. [Study on the relationship between epidermal growth factor and fetal growth retardation].
Dong M; He J; Wang Z
Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):135-7. PubMed ID: 11263179
[TBL] [Abstract][Full Text] [Related]
13. Amniotic fluid and plasma glycine/valine ratios in substrate deprived growth retarded fetal rats.
Bernstein IM; Rhodes S; Stirewalt WS
J Dev Physiol; 1992 Jun; 17(6):277-81. PubMed ID: 1289390
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
15. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta.
Kauppila S; Tekay A; Risteli L; Koivisto M; Risteli J
Eur J Clin Invest; 1998 Oct; 28(10):831-7. PubMed ID: 9792997
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of perinatal outcome using individualized growth assessment: comparison with conventional methods.
Ariyuki Y; Hata T; Kitao M
Pediatrics; 1995 Jul; 96(1 Pt 1):36-42. PubMed ID: 7596719
[TBL] [Abstract][Full Text] [Related]
17. Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies.
Varner MW; Dildy GA; Hunter C; Dudley DJ; Clark SL; Mitchell MD
J Soc Gynecol Investig; 1996; 3(1):17-9. PubMed ID: 8796801
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size.
Hill DJ; Tevaarwerk GJ; Caddell C; Arany E; Kilkenny D; Gregory M
J Clin Endocrinol Metab; 1995 Sep; 80(9):2626-32. PubMed ID: 7673405
[TBL] [Abstract][Full Text] [Related]
19. The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term.
Osmanağaoğlu MA; Osmanağaoğlu S; Bozkaya H
J Perinat Med; 2005; 33(2):149-55. PubMed ID: 15843266
[TBL] [Abstract][Full Text] [Related]
20. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
